Research output per year
Research output per year
- 21 results
Search results
-
2016
MTORC1 inhibition for epilepsy in TSC
Sparagana, S. P., Sep 6 2016, In: Neurology. 87, 10, p. 974-975 2 p.Research output: Contribution to journal › Editorial › peer-review
1 Scopus citations -
Targeting "bad" B cells in multiple sclerosis: Could laquinimod be part of the armamentarium?
Forsthuber, T. G. & Stuve, O., Oct 1 2016, In: Neurology: Neuroimmunology and NeuroInflammation. 3, 5, e283.Research output: Contribution to journal › Editorial › peer-review
Open Access -
The Mexican Academy for Cerebral Palsy and Neurodevelopmental Disorders: New kid on the block
Delgado, M. R., Feb 1 2016, In: Developmental Medicine and Child Neurology. 58, 2, p. 109 1 p.Research output: Contribution to journal › Editorial › peer-review
Open Access2 Scopus citations -
2015
Natalizumab to fingolimod: Questions answered, unanswered, and unasked
Stüve, O. & Bourdette, D., Jul 7 2015, In: Neurology. 85, 1, p. 14-15 2 p.Research output: Contribution to journal › Editorial › peer-review
-
Smoking beyond multiple sclerosis diagnosis: A risk factor still worth modifying
Goldman, M. D. & Stüve, O., Oct 1 2015, In: JAMA neurology. 72, 10, p. 1105-1106 2 p.Research output: Contribution to journal › Editorial › peer-review
-
Treatment decisions for patients with active multiple sclerosis
Stüve, O. & Centonze, D., Apr 1 2015, In: JAMA neurology. 72, 4, p. 387-389 3 p.Research output: Contribution to journal › Editorial › peer-review
3 Scopus citations -
2014
Does natalizumab therapy benefit patients with multiple sclerosis?
Stüve, O. & Cutter, G. R., Aug 2014, In: JAMA neurology. 71, 8, p. 945-946 2 p.Research output: Contribution to journal › Editorial › peer-review
3 Scopus citations -
Neuroinflammation of the central and peripheral nervous system: An update
Stüve, O. & Zettl, U., Mar 2014, In: Clinical and Experimental Immunology. 175, 3, p. 333-335 3 p.Research output: Contribution to journal › Editorial › peer-review
18 Scopus citations -
The genetics of natalizumab hypersensitivity: One learns to itch where one can scratch
Stüve, O. & Hemmer, B., Dec 2014, In: Neurology: Neuroimmunology and NeuroInflammation. 1, 4, e52.Research output: Contribution to journal › Editorial › peer-review
Open Access2 Scopus citations -
2013
A bird's-eye view of T cells during natalizumab therapy
Hohlfeld, R. & Stüve, O., Oct 15 2013, In: Neurology. 81, 16, p. 1372-1373 2 p.Research output: Contribution to journal › Editorial › peer-review
3 Scopus citations -
2012
Time to talk about timing - When to start, stop and change anti-migratory drugs in MS
Stüve, O. & Hemmer, B., Nov 2012, In: Multiple Sclerosis Journal. 18, 11, p. 1514-1516 3 p.Research output: Contribution to journal › Editorial › peer-review
2 Scopus citations -
2009
200 years after darwin
Rosenberg, R. N., Stüve, O. & Eagar, T., Feb 2009, In: Archives of neurology. 66, 2, p. 153-155 3 p.Research output: Contribution to journal › Editorial › peer-review
1 Scopus citations -
Iatrogenic immunosuppression with biologics in MS: Expecting the unexpected?
Stüve, O. & Wiendl, H., Oct 2009, In: Neurology. 73, 17, p. 1346-1347 2 p.Research output: Contribution to journal › Editorial › peer-review
9 Scopus citations -
Immunotherapy for multiple sclerosis: The curious case of interferon beta
Stüve, O. & Ransohoff, R. M., 2009, In: Archives of neurology. 66, 10, p. 1193-1194 2 p.Research output: Contribution to journal › Editorial › peer-review
3 Scopus citations -
Visualizing the cause of gray matter atrophy in multiple sclerosis
Richert, N. D., Kraft, E. & Stüve, O., Feb 2009, In: Archives of neurology. 66, 2, p. 159-160 2 p.Research output: Contribution to journal › Editorial › peer-review
-
2008
Fine-tuning the homeostasis of regulatory T cells: New mechanism of immunomodulatory therapy in multiple sclerosis
Hofstetter, H. H., Stüve, O. & Hartung, H. P., Nov 1 2008, In: Archives of neurology. 65, 11, p. 1417-1418 2 p.Research output: Contribution to journal › Editorial › peer-review
2 Scopus citations -
Natalizumab: Increased vigilance is required in treating patients with multiple sclerosis
Racke, M. K. & Stüve, O., Nov 2008, In: Therapeutic Advances in Neurological Disorders. 1, 3, p. 155-156 2 p.Research output: Contribution to journal › Editorial › peer-review
Open Access2 Scopus citations -
2007
DNA plasmid vaccination for multiple sclerosis
Stuve, O., Eagar, T. N., Frohman, E. & Cravens, P. D., Oct 2007, In: Archives of neurology. 64, 10, p. 1385-1386 2 p.Research output: Contribution to journal › Editorial › peer-review
5 Scopus citations -
2006
Statins and the blood-brain barrier: Plugging the holes
Stüve, O., Jul 2006, In: Annals of Neurology. 60, 1, p. 1-2 2 p.Research output: Contribution to journal › Editorial › peer-review
4 Scopus citations -
2004
Viral pathogens in multiple sclerosis: An intriguing (hi)story
Stüve, O., Racke, M. & Hemmer, B., Oct 2004, In: Archives of neurology. 61, 10, p. 1500-1502 3 p.Research output: Contribution to journal › Editorial › peer-review
15 Scopus citations -
1996
Guillain-Barre syndrome: A pediatric challenge
Delgado, M. R., 1996, In: Journal of child neurology. 11, 1, p. 1-3 3 p.Research output: Contribution to journal › Editorial › peer-review
Open Access8 Scopus citations